Efficacy Of Erythromycin Phonophoresis on Chronic Rhinosinusitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-50
SponsorCairo University

About this trial

The purpose of the study is to evaluate the therapeutic effect of erythromycin phonophoresis in reducing chronic rhinosinusitis.

Eligibility criteria

Qualifiers

Age range between 25-50 years.

Male and female patients will participate in the study.

All patients have chronic rhinosinusitis.

All patients enrolled in the study will have their informed consent.

Disqualifiers

Patients with pacemaker

Patients diagnosed with cancer.

Pregnant women

Patients with impaired vascular circulation

Trial design

Treatments tested in this trial

  • Erythromycin Phonophoresis
  • Ultrasound (US)
  • Topical Erythromycin
  • Medical treatment

Treatment groups

90 Participants
are divided into 3 treatment groups

Sponsors and collaborators